Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study

Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason

Research output: Contribution to journalJournal articleResearchpeer-review

23 Citations (Scopus)
268 Downloads (Pure)
Original languageEnglish
Article numbere0141377
JournalPLoS ONE
Volume10
Issue number10
Number of pages11
ISSN1932-6203
DOIs
Publication statusPublished - 2015

Fingerprint Dive into the research topics of 'Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study'. Together they form a unique fingerprint.

  • Cite this

    Pallisgaard, J. L., Lindhardt, T. B., Hansen, M. L., Schjerning, A-M., Olesen, J. B., Staerk, L., Torp-Pedersen, C., & Gislason, G. H. (2015). Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study. PLoS ONE, 10(10), [e0141377]. https://doi.org/10.1371/journal.pone.0141377